A simplified view of Victor Dzau´s cardiovascular continuum
•Download as PPT, PDF•
0 likes•1,126 views
By Luis Miguel Ruilope, MD, Professor, Internal Medicine, Complutense University, Head of the Hypertension Unit, 12 de Octubre Hospital, Madrid, Spain.
More Related Content
What's hot
What's hot (20)
Viewers also liked
Viewers also liked (17)
Similar to A simplified view of Victor Dzau´s cardiovascular continuum
Similar to A simplified view of Victor Dzau´s cardiovascular continuum (20)
More from My Healthy Waist
More from My Healthy Waist (20)
Recently uploaded
Recently uploaded (20)
A simplified view of Victor Dzau´s cardiovascular continuum
- 1. A Simplified View of Victor Dzau´s Cardiovascular Continuum Luis Miguel Ruilope, MD Head of Hypertension Unit 12 de Octubre Hospital, Madrid, Spain
- 2. Cardio-renal Continuum REGRESS RETARD Target organ damage Asymptomatic Target organ damage Symptomatic Death CKD New risk factors Risk factors Cardiometabolic risk PREVENT Atherosclerosis ESRD Source: International Chair on Cardiometabolic Risk www.cardiometabolic-risk.org CKD : chronic kidney disease ESRD : end-stage renal disease
- 3. Cardio-renal Continuum REGRESS RETARD Target organ damage Asymptomatic CKD New risk factors Risk factors Cardiometabolic risk PREVENT Source: International Chair on Cardiometabolic Risk www.cardiometabolic-risk.org Target organ damage Symptomatic Death Atherosclerosis ESRD CKD : chronic kidney disease ESRD : end-stage renal disease
- 4. %EVENTS vs. COST %EVENTS 1 2 3 COST 75 % 25 %
Editor's Notes
- The animation shows that the earlier the intervention, the greater the protection it affords.
- The animation shows that the earlier the intervention, the greater the protection it affords.
- The size of the three stages refers to the size of the population in each stage. The biggest section is stage 1 and the smallest section is stage 3. However, it is stage 3 that has the highest intervention cost even though it accounts for only some 25% of deaths. Proper stratification of risk in stage 1 by identifying cardiovascular and renal risk factors and providing early detection of target organ damage will enable interventions, including those for cardiometabolic risk, to be more effective and more comprehensive.